AL
Alfresa Holdings Corporation
ALFRY · OTC
$13.55 +0.00% (+$0.00)
Market Cap ¥378.8B
P/E Ratio 9.49x
Div. Yield 3.26%
ROE 8.08%
Bulios Fair Price
$19.36
42.9% upside
Current Price
$13.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALFRY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap EV/EBITDA 4.15x
P/S 0.12x
P/B 0.79x
Growth
32 /100
Declining Rev. growth 4.62%
Book val. growth 0.72%
EPS growth 1.33%
Profitability
6 /100
Weak Net margin 1.25%
Op. margin 1.11%
FCF margin 0.00%
Quality
39 /100
Average ROE 8.08%
ROA 2.66%
Asset turnover 2.13x
Debt
93 /100
Low Current ratio 1.21x
Int. coverage 97.57x
Net debt/EBITDA -3.07x
Stability
84 /100
Stable Rev. volatility 1.26%
EPS volatility 19.33%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALFRY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Ryuji Arakawa
Employees
12,525
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
07 DEC
Dividend Payment
Payment date